Comparative Study of Olanzapine versus Haloperidol in the Treatment of Schizoaffective Disorder.

Simple item page
dc.contributor.authorBrar, Gurmeet kaur
dc.contributor.authorArora, Monica
dc.contributor.authorBrar, Hargurpal Singh
dc.contributor.authorSachdeva, Jaswant Singh
dc.date.accessioned2017-01-17T04:41:08Z
dc.date.available2017-01-17T04:41:08Z
dc.date.issued2016-11
dc.description.abstractBackground: The growing awareness of the impact of antipsychotic drug on patients quality of life has created the need for deeper insight into the side effects, other best drug for the treatment of schizoaffective disorder. Objective:- The study was conducted to find out whether olanzapine is more safe than haloperidol in treating schizoaffective disorder and compare the overall clinical efficacy of Olanzapine Vs haloperidol in Schizoaffective disorder. Methods: The sample was taken from sixty patients fulfilling ICD-10 criteria for schizoaffective disorder consenting for study attending the psychiatry OPD and emergency of G.G.S. Medical College and Hospital Faridkot aged between 15-60 years the patients were selected from either sex. After screening the patients who were found positive for schizoaffective disorder, Then these patients were divided into two groups and put on medicine olanzapine (n=30) and tab Haloperidol (n=30) for six weeks. After that all the patients further assessed for clinical status and side effects using BPRS, PANSS, CGI scale, UKU Side Effect Rating Scale and final diagnosis was made according to ICD-10 criteria. Results: The current study was a randomized, double blind, parallel design comparative trial between olanzapine and haloperidol for a period of six weeks for the management of schizoaffective disorder. Total 60 patients who met ICD-10 criteria for schizoaffective disorder were randomly allocated: 30 each in olanzapine and haloperidol groups. 55 patients had completed the protocol .27 in haloperidol group and 28 in olanzapine group. In our study, in haloperidol group we had 8 schizoaffective manic type and 9 schizoaffective depressive type patients, while in case of olanzapine group the number of schizoaffective manic type was 7 and depressive type was 21 i.e. comparable in both groups. Conclusion: The results of the study revealed that overall superior efficacy and safety advantage of olanzapine over haloperidol suggests that olanzapine represents an important alternate treatment option in schizoaffective disorder. These positive findings are encouraging prospective trails in related disorders such as bipolar depression, depression with psychotic features or other psychotic states with prominent mood symptoms.en_US
dc.identifier.citationBrar Gurmeet kaur, Arora Monica, Brar Hargurpal Singh, Sachdeva Jaswant Singh. Comparative Study of Olanzapine versus Haloperidol in the Treatment of Schizoaffective Disorder. Annals of International Medical and Dental Research. 2016 Nov-Dec; 2(6): 1-7.en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/181852
dc.language.isoenen_US
dc.source.urihttps://aimdrjournal.com/pdf/vol2Issue6/PY1_OA_Gurmeet_2_6_55.pdfen_US
dc.subjectHaloperidolen_US
dc.subjectOlanzapineen_US
dc.subjectSchizoaffective Disorderen_US
dc.titleComparative Study of Olanzapine versus Haloperidol in the Treatment of Schizoaffective Disorder.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
aimdr2016v2n6p1-7.pdf
Size:
132.87 KB
Format:
Adobe Portable Document Format
Description:
Original article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Annals of International Medical and Dental Research